Skip to content
  • What We Do
    • Financial Statements
    • Disclosures
    • Privacy
    • Terms Of Use
    • Multi-Asset Clearing 
    • Technology
    • Investment Banking & Capital Markets
    • Equity Research
    • Prime Brokerage
    • Wealth Management
    • Investment Management
    • List Item #1
    • List Item #2
    • List Item #3
    • List Item
    • List Item
  • Solution Guide
  • Company
    • Financial Statements
    • Disclosures
    • Privacy
    • Terms Of Use
    • About Us
    • Leadership
    • Career Opportunities
    • Community
    • Affiliates
  • Insights
  • What We Do
    • Financial Statements
    • Disclosures
    • Privacy
    • Terms Of Use
    • Multi-Asset Clearing 
    • Technology
    • Investment Banking & Capital Markets
    • Equity Research
    • Prime Brokerage
    • Wealth Management
    • Investment Management
    • List Item #1
    • List Item #2
    • List Item #3
    • List Item
    • List Item
  • Solution Guide
  • Company
    • Financial Statements
    • Disclosures
    • Privacy
    • Terms Of Use
    • About Us
    • Leadership
    • Career Opportunities
    • Community
    • Affiliates
  • Insights
Contact Us
Login
What We Do
  • Multi-Asset Clearing
  • Technology
  • Equity Research
  • Prime Brokerage
  • Wealth Management
  • Investment Management
Solution Guide
Company
  • About Us
  • A Look Back
  • Ed’s Edicts
  • Leadership
  • Career Opportunities
  • Community
  • Financial Statements
  • Find a Financial Professional
Insights
Search
Contact Us

Day: August 14, 2019

Daniel Ives: There’s a Little More Focus Among Investors for WeWork to Carry the Torch

For more on Daniel Ives’ comments: WeWork IPO filing follows uneven road for other companies going public 

Daniel Ives: The Delay Removes a Major Near-Term Dark Cloud over Apple

For more on Daniel Ives’ comments: Apple lifted by delay in U.S. tariffs on electronics made in China

David Nierengarten Reiterated a Buy Rating on Kiniksa Pharmaceuticals Ltd

David Nierengarten’s rating reiteration and five-star overall rating was mentioned on Analyst Ratings. For more, click here.

Al Kluis: The Recent Crop Progress Report Showed That Soybeans Setting Pods Is at 54% This Year

For more on Al Kluis’ comments: AG markets trade mixed Wednesday 

Michael Pachter: Fewer Cable Subscribers Means Lower Retransmission Rates

For more on Michael Pachter’s comments: How Disney’s amazing streaming bundle deal can actually hurt them

Daniel Ives: The U.S. Sanctioned Taxes Would Have Cut Apple’s Sales by 51 to 56 Cents per Share

For more on Daniel Ives’ comments: Apple stocks defy market pressure with record 1-day climb

Daniel Ives: The Delay of Tariffs Removed a Major Near-Term Dark Cloud for Apple

For more on Daniel Ives’ comments: These stocks rose the most as Trump backed off (a bit) from tariffs

Daniel Ives: Early Uber Investors May Use the Lockup Period Expiration to Dump the Stock

For more on Daniel Ives’ comments: Uber stock fell to an all-time low yesterday

Daniel Ives: Apple’s New iPhones Will Be Very Similarly Priced to Last Year’s Models

For more on Daniel Ives’ comments: New iPhone ‘coming in THREE versions this September’ – as experts squash rumours of delayed ‘cheap’ model

Daniel Ives: Apple’s Price Cut Was Solely to Improve Sales in the China Market

For more on Daniel Ives’ comments: New iPhone 11 price ‘revealed’ as CHEAPER than 2018 models according to expert predictions 

Next →

Find a Financial Professional

Get the support you need to plan your financial future.
Find Now
  • What We Do
  • Solution Guide
  • Company
  • Insights
  • Contact Us
  • Financial Statements
  • Wedbush & Co.
  • Disclosures
  • Privacy
  • Terms Of Use
  • Member NYSE / FINRA / SIPC
  • Broker Check
  • 225 S. Lake Ave., Penthouse, Pasadena | CA | 91101
  • 213.688.8000